Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis.

Nakamura MM, Liew SY, Cummings CA, Brinig MM, Dieterich C, Relman DA.

Infect Immun. 2006 Oct;74(10):5537-48.

2.

Genomic features of Bordetella parapertussis clades with distinct host species specificity.

Brinig MM, Register KB, Ackermann MR, Relman DA.

Genome Biol. 2006;7(9):R81.

3.

Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation.

Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA.

J Bacteriol. 2006 Apr;188(7):2375-82.

4.

Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica.

Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR.

PLoS Pathog. 2005 Dec;1(4):e45. Epub 2005 Dec 30.

5.

Methanogenic Archaea and human periodontal disease.

Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6176-81. Epub 2004 Apr 5.

6.

Bordetella species are distinguished by patterns of substantial gene loss and host adaptation.

Cummings CA, Brinig MM, Lepp PW, van de Pas S, Relman DA.

J Bacteriol. 2004 Mar;186(5):1484-92.

7.

Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease.

Brinig MM, Lepp PW, Ouverney CC, Armitage GC, Relman DA.

Appl Environ Microbiol. 2003 Mar;69(3):1687-94.

8.

Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.

Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB.

Infect Immun. 2002 Mar;70(3):1507-17.

Supplemental Content

Loading ...
Support Center